Today

Agents

Chat

Arena

Discover

More

App

Spyre Therapeutics CEO Turtle Cameron sells common shares worth $1.42 million - SYRE News | Rallies

Spyre Therapeutics CEO Turtle Cameron sells common shares worth $1.42 million

SYRE•2026-08-06

CEO sold shares in August 3 transactions

Spyre Therapeutics CEO Turtle Cameron sold 15,000 common shares on Aug. 3 at weighted-average prices of $93.97 to $97.46.
Cameron’s direct holdings fell to 567,540 shares following the transactions.

Related News

Gold touches seven-week high on Strait of Hormuz reopening hopes

GLD•2026-08-06

CytomX Therapeutics Chief Legal Officer Alejandra Carvajal files initial beneficial ownership statement

CTMX•2026-08-05

British Business - August 6

Sources

S

Spyre Therapeutics CEO Turtle Cameron sells common shares worth $1.42 million

Sec

2026-08-06

Rockwell Automation Inc <ROK.N>: JPMorgan Raises Target Price to $426 From $417

ROK•2026-08-06

Nasdaq Trade Halt <BYAH.O> Halt News Pending at 07:50 PM

BYAH•2026-08-05